Our mission
To develop and implement recommendations that will improve the impact, quality and efficiency of clinical trials, leading to more rapid, lower cost and higher quality evaluation of healthcare interventions in Australia.
Our vision
To act as a platform for all stakeholder voices to come together and continually improve the clinical trials field in Australia, enabling efficient and effective, patient-centred, clinical trials.
News
Welcome Pharmaceutical Product Development (PPD) to CT:IQ Steering Committee
CT:IQ is delighted to welcome Pharmaceutical Product Development (PPD) to the Steering Committe. PPD, part of Thermo Fisher Scientific, is a leading global contract research organisation (CRO) focused on delivering life-changing therapies. PPD provides comprehensive lab services, integrated drug development, clinical trial therapeutic expertise and lifecycle management services. In December 2021, PPD became a wholly owned […]